Product Information

TADALAFIL 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1043 per EA under NDC 00480230965. Its NADAC has been published 62 times since Dec 25, 2024.

FDA first approved this application on Mar 29, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Tadalafil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TADALAFIL 5 MG TABLET

Tadalafil
$0.1043per EA
Low Outlier

Strength

5 mg/1

NDC

00480230965

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

2/18/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA205885

FDA Approved

3/29/2019

TE Code

AB1

On Market Since

1/16/2024

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 5 MG TABLET has been published 62 times since Dec 25, 2024, and over the history we have for it it has risen 4.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1043 per EA
All-time high$0.1231 (Oct 15, 2025)
All-time low$0.0980 (Jan 22, 2025)
52-week high$0.1227
52-week low$0.1043
Median price$0.1116
Average price$0.1118
Largest weekly change+9.5% (Feb 19, 2025)
Weeks tracked62
Tracking sinceDec 25, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

-15.0%

3Y

N/A

5Y

N/A

All

+4.0%

Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1043 per EA (NDC 00480230965), effective Feb 25, 2026.

How has the price of TADALAFIL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has risen 4.0%. It has been tracked across 62 weekly CMS publications since Dec 25, 2024.

What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?

Since Dec 25, 2024, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0980 (Jan 22, 2025) to a high of $0.1231 (Oct 15, 2025), with a median of $0.1116 per EA.

Are there cheaper alternatives to TADALAFIL 5 MG TABLET?

15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TADALAFIL 5 MG TABLET?

TADALAFIL 5 MG TABLET (NDC 00480230965) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.